SMS (investment case): Second half sets the direction, cost actions and capital reduction in focus
20 maj, 14:15
20 maj, 14:15
Following the publication of Scandinavian Medical Solutions (SMS) H1 2025/26 half-year report on 19 May 2026, we have updated our investment case. The update reflects the H1 results, the maintained 2025/26 guidance, and the six H2 2025/26 focus areas presented by management, implemented to turn the earnings around and improve capital position.
20 maj, 14:15
Following the publication of Scandinavian Medical Solutions (SMS) H1 2025/26 half-year report on 19 May 2026, we have updated our investment case. The update reflects the H1 results, the maintained 2025/26 guidance, and the six H2 2025/26 focus areas presented by management, implemented to turn the earnings around and improve capital position.
Aktieanalys
Aktierekar
Riksdagsvalet

Aktieanalys
Aktierekar
Riksdagsvalet

1 DAG %
Senast
OMX Stockholm 30
0,04%
(vid stängning)
NCAB Group
Igår, 15:46
NCAB köper amerikanskt bolag
OMX Stockholm 30
1 DAG %
Senast
3 146,96